Michael Houghton is shown in a University of Alberta handout photo. British scientist Houghton, who works at the University of Alberta, and Americans Harvey J. Alter and Charles M. Rice were awarded the Nobel Prize for Medicine or Physiology on Monday for the discovery of the hepatitis C virus. THE CANADIAN PRESS/HO-University of Alberta MANDATORY CREDIT

U of A researcher shares Nobel prize for hepatitis C virus discovery

WHO estimates there are over 70 million cases of hepatitis C worldwide and 400,000 deaths from it each year

British scientist Michael Houghton, who works at the University of Alberta, and Americans Harvey J. Alter and Charles M. Rice were awarded the Nobel Prize for Medicine or Physiology on Monday for the discovery of the hepatitis C virus.

Announcing the prize in Stockholm, the Nobel Committee noted that the men’s work identified a major source of blood-borne hepatitis that couldn’t be explained by the previously discovered hepatitis A and B viruses. Their work, dating back to the 1970s and 1980s, has helped saved millions of lives, it said.

“Thanks to their discovery, highly sensitive blood tests for the virus are now available and these have essentially eliminated post-transfusion hepatitis in many parts of the world, greatly improving global health,” the committee said.

“Their discovery also allowed the rapid development of antiviral drugs directed at hepatitis C,” it added. “For the first time in history, the disease can now be cured, raising hopes of eradicating hepatitis C virus from the world population.”

Houghton is director of the University of Alberta’s Li Ka Shing Applied Virology Institute.

“Michael Houghton’s achievement cannot be overstated,” said University of Alberta president Bill Flanagan. “Dr. Houghton has made this world a better place. As president of the University of Alberta, the institution where he has dedicated his time, I am proud and exhilarated that his work has been recognized in this way.”

The hepatitis C virus is a major source of liver disease that affects millions worldwide.

WHO estimates there are over 70 million cases of hepatitis C worldwide and 400,000 deaths from it each year. The disease is chronic and a major cause of liver cancer and cirrhosis requiring liver transplants.

John McLauchlan, a professor of viral hepatitis at the University of Glasgow, called the three laureates “pioneers” and said their discovery made the global elimination of the disease possible. In 2016, the World Health Organization issued a strategy to wipe out the disease by 2030.

“That would mark the first time we might possibly control a viral infection using only drugs,” McLauchlan said.

“The only issue is getting drugs to people and places where they desperately need them,” he said, adding that the disease primarily strikes stigmatized populations like drug users and the poor.

Alter, who was born in 1935 in New York, carried out his prize-winning studies at the U.S. National Institutes of Health in Bethesda, where he remains active, the committee said. Rice, born in 1952 in Sacramento, California, worked on hepatitis at Washington University in St. Louis and now works at Rockefeller University in New York. Houghton, born in Britain in 1950, studied at the Chiron Corporation in California before moving to the University of Alberta in Edmonton.

The medicine prize carried particular significance this year due to the coronavirus pandemic, which has highlighted the importance that medical research has for societies and economies around the world.

Will Irving, a virologist at the University of Nottingham, said that identifying hepatitis C had been the “holy grail” in medicine.

“After hepatitis A and B were discovered in the 1970s, it was clear there was still at least one other virus or more that were causing liver damage,” he said.

“We knew there was a virus in the blood supply, because when people had blood transfusions they would get liver damage,” Irving said. “It was recognized as a risk but there was nothing we could do. We didn’t know what the virus was and we couldn’t test for it.”

Nobel Committee member Patrik Ernfors drew a parallel between this year’s prize and the current rush by millions of scientists around the world to combat the coronavirus pandemic.

“The first thing you need to do is to identify the causing virus,” he told reporters. “And once that has been done, that is, in itself, the starting point for development of drugs to treat the disease and also to develop vaccines against the disorder.”

Unlike hepatitis A, which is transmitted via food or water and causes an acute infection that can last a few weeks, hepatitis B and C are transmitted through blood.

American scientist Baruch Blumberg discovered the hepatitis B virus in 1967 and received the 1976 Nobel Prize in medicine, but this did not explain all cases of chronic hepatitis, a disease that was becoming more common even in apparently healthy people who had received or given blood.

“Before the discovery of the hepatitis C virus, it was a bit like Russian roulette to get a blood transfusion,” said Nobel Committee member Nils-Goran Larsson.

Alter was working at the U.S. National Institutes of Health when he discovered that plasma from patients who didn’t have hepatitis B could also could transfer the disease.

“The breakthrough came in 1989, when Michael Houghton and colleagues working at Chiron Corporation used a combination of molecular biology and immunology-based techniques to clone the virus,” said Nobel Committee member Gunilla Karlsson-Hedestam.

Later, Rice confirmed that a cloned hepatitis virus alone could cause persistent infection in chimpanzees and reproduce the disease observed in humans.

The hepatitis C virus belongs to a group known as flaviviruses that also includes West Nile virus, dengue virus and yellow fever virus.

Thomas Perlmann, the Secretary-General of the Nobel Committee, managed Monday to reach two of the winners, Alter and Rice.

“I had to call a couple of times before they answered,” he said. “They seemed very surprised and very, very happy.”

Graham Foster, professor of hepatology at Queen Mary University, said the discovery of hepatitis C had prevented millions from getting sick or dying of the disease or other liver problems and that the awarding of the Nobel to Alter, Houghton and Rice was very well deserved.

Foster said the discovery has had significant impacts in both developing countries, like Egypt and Pakistan, where millions were infected via contaminated medical equipment or procedures, and in developed countries like the U.S., where the blood supply itself was often contaminated.

“This discovery allowed for safe blood transfusion and it allowed the rapid development of treatments for hepatitis C,” Foster said. “We are now in a position where we have drugs that are 96% effective if you take a pill for eight weeks.”

The Nobel Committee often recognizes basic science that has laid the foundations for practical applications in common use today.

“It takes time before it’s fully apparent how beneficial a discovery is,” said Perlmann. “Of course these serological tests have been around for quite a while, but the antiviral drugs that emerged as a consequence of this significant discovery have been much more recent.”

The prestigious Nobel award comes with a gold medal and prize money of 10 million Swedish kronor (over US$1,118,000), courtesy of a bequest left 124 years ago by the prize’s creator, Swedish inventor Alfred Nobel.

Monday’s medicine award is the first of six prizes this year being announced through Oct. 12. The other prizes are for outstanding work in the fields of physics, chemistry, literature, peace and economics.

David Keyton And Frank Jordans, The Associated Press

Like us on Facebook and follow us on Twitter.

Want to support local journalism? Make a donation here.

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Alberta has 3,651 active cases of COVID-19. (File photo)
432 new COVID cases sets another record Friday

Central zone holds steady at 126 active cases

"We are looking seriously at the spread and determining what our next steps should be," says Alberta’s chief medical officer of health, Dr. Deena Hinshaw, as the daily number of COVID-19 cases continues to climb.
427 new COVID cases is highest in Alberta ever

Central zone has 126 active cases of COVID-19

COVID-19. (Image courtesy CDC)
Temporary COVID-19 testing sites coming to Wetaskiwin and Ponoka

The Wetaskiwin location will open Oct. 23, 2020 and the Ponoka location will open Oct. 29.

COVID-19. (Image courtesy CDC)
City and County of Wetaskiwin reporting active cases

Both the City of Wetaskiwin and County of Wetaskiwin have active cases.

Alberta chief medical officer of health Dr. Deena Hinshaw updates media on the Covid-19 situation in Edmonton on Friday March 20, 2020. nbsp;Alberta is reporting it's highest daily number of COVID-19 cases, with 364 new infections. THE CANADIAN PRESS/Jason Franson
Alberta confirmed 323 COVID-19 cases Tuesday

Central zone active cases at 145

B.C. Liberal leader Andrew Wilkinson, B.C. NDP leader John Horgan and B.C. Greens leader Sonia Furstenau. (Black Press Media)
VIDEO: One day until B.C. voters go to the polls in snap election defined by pandemic

NDP Leader John Horgan’s decision to call an election comes more than a year ahead of schedule and during a pandemic

This photo provided by Air Force Reserve shows a sky view of Hurricane Epsilon taken by Air Force Reserve hurricane hunter team over the Atlantic Ocean taken Wednesday, Oct. 21, 2020.   Epsilon’s maximum sustained winds have dropped slightly as it prepares to sideswipe Bermuda on a path over the Atlantic Ocean.  The National Hurricane Center says it should come close enough Thursday, Oct. 22, evening to merit a tropical storm warning for the island.  (Air Force Reserve via AP)
Hurricane Epsilon expected to remain offshore but will push waves at Atlantic Canada

Epsilon is not expected to have any real impact on land

A voter places her absentee ballot in the ballot box, Wednesday, Oct. 7, 2020, at Merrill Auditorium in Portland, Maine. THE CANADIAN PRESS/AP/Robert F. Bukaty
American voters living in Canada increasingly being counted in presidential race

The largest number of Canadian-based American voters cast their ballots in New York and California

A composite image of three photographs shows BC NDP Leader John Horgan, left, in Coquitlam, B.C., on Sept. 25, 2020; BC Green Party Leader Sonia Furstenau, centre, in Victoria on Sept. 24, 2020; and BC Liberal Party Leader Andrew Wilkinson Pitt Meadows, B.C., on Sept. 24, 2020. THE CANADIAN PRESS/Darryl Dyck, Chad Hipolito
British Columbia votes in snap election called during COVID-19 pandemic

NDP Leader John Horgan called the snap election one year before the fixed voting date

Nunavut's provincial flag flies on a flag pole in Ottawa, on Tuesday June 30, 2020. The annual report from Nunavut's representative for children and youth says "complacency and a lack of accountability" in the territory's public service means basic information about young people needing services isn’t tracked. THE CANADIAN PRESS/Adrian Wyld
Nunavut’s young people ‘should be expecting more’ from government services: advocate

‘The majority of information we requested is not tracked or was not provided by departments’

Ryen Williams, 11, with a lost miniature horse at JJ Collett Oct. 23. Photo by Don Williams
UPDATE: Owners found

Father and son found him while out for a walk at JJ Collett

A Le Chateau retail store is shown in Montreal on Wednesday July 13, 2016. Le Chateau Inc. says it is seeking court protection from creditors under the Companies’ Creditors Arrangement Act to allow it to liquidate its assets and wind down its operations.THE CANADIAN PRESS/Ryan Remiorz
Clothing retailer Le Chateau plans to close its doors, files for CCAA protection

Le Chateau said it intends to remain fully operational as it liquidates its 123 stores

U.S. border officers at the Peace Arch crossing arrested two men on California warrants this week. (File photo)
Ottawa predicts system delays, backlogs unless court extends life of refugee pact

Canada and the United States recognize each other as safe places to seek protection

Conservative member of Parliament Michelle Rempel Garner, left to right, Conservative Leader Erin O’Toole and Conservative Deputy Leader Candice Bergen arrive to hold a press conference in Ottawa on Thursday, Oct. 22, 2020. THE CANADIAN PRESS/Sean Kilpatrick
No-confidence showdown over sweeping Tory motion on government handling of pandemic

The Conservative motion is to be put to a vote Monday and has the support of both the Bloc Québécois and NDP

Most Read